Human coronavirus (hCoV) HKU1 is one of six hCoVs identified to date and the only one 45 with an unidentified cellular receptor. HCoV-HKU1 encodes a hemagglutinin-esterase (HE) 46 protein that is unique to the betacoronaviruses group a (group 2a). The function of HKU1-HE 47 remains largely undetermined. In this study, we examined binding of the S1 domain of 48 hCoV-HKU1 spike to a panel of cells and found that the S1 could specifically bind on the cell 49 surface of a human rhabdomyosarcoma cell line, RD. Pretreatment of RD cells with 50 neuramidase (NA) and trypsin greatly reduced the binding, suggesting that the binding was 51 mediated by sialic acids on glycoproteins. However, unlike other group 2a CoVs, e.g. 52 hCoV-OC43 for which 9-O-acytylated sialic acid (9-O-Ac-Sia) servers as a receptor 53 determinant, HKU1-S1 neither bound with 9-O-Ac-Sia containing glycoprotein(s), nor rat and 54 mouse erythrocytes. Nonetheless, the HKU1-HE was similar to OC43-HE, also possessed 55 sialate-O-acetylesterase activity and acted as a receptor-destroying enzyme (RDE) capable 56 of eliminating the binding of HKU1-S1 to RD cells, whereas the O-acetylesterase inactive 57 HKU1-HE mutant lost this capacity. Using primary human ciliated airway epithelial cell 58 cultures (HAE), the only in vitro replication model for hCoV-HKU1 infection, we confirmed that 59 pretreatment of HAE cells with HE but not the enzymatically inactive mutant blocked 60 hCoV-HKU1 viral infection. These results demonstrate that hCoV-HKU1 exploits O-AC-Sia as 61 a cellular attachment receptor determinant to initiate the infection of host cells, and its HE 62 protein possesses the corresponding sialate-O-acetylesterase RDE activity. 63 64 65 3 / 25 Importance statement 66 67 Human coronaviruses (hCoV) are important human respiratory pathogens. Among the six 68
Introduction 79 80
Human coronaviruses (hCoV) are enveloped RNA viruses. They are usually associated 81 with mild to moderate respiratory tract illnesses, but can also cause severe and highly lethal 82 disease depending on the virus strain (1) . Six hCoV strains have been identified to date and 83 belong to four different groups, including hCoV-229E and hCoV-NL63 in the 84 alphacoronaviruses (group 1); hCoV-OC43 and hCoV-HKU1 in the betacoronaviruses group a 85 (group 2a); severe acute respiratory syndrome CoV (SARS-CoV) in the betacoronaviruses 86 group b (group 2b); and Middle East Respiratory Syndrome CoV (MERS-CoV) in the 87 betacoronaviruses group c (group 2c). Infections by viruses in groups 1 and 2a are common 88 worldwide, and can also cause severe disease in young children or immunocompromised 89 adults. SARS-CoV (2-4) and MERS-CoV (5, 6) are two highly virulent hCoVs causing severe 90 respiratory diseases with high morbidity and mortality (7); the latter strain is still circulating in 91 human populations. 92 93 Cellular receptor specificity plays an important role in viral cell and tissue tropism, 94 pathogenesis, interspecies transmission and adaptation. The CoV Spike (S) glycoprotein is 95 generally responsible for binding to cellular receptors and mediating viral entry. S protein is a 96 large type-I transmembrane glycoprotein that exists as a trimer protruding from the surface of 97 virions (8). S proteins have an amino-terminal (NT) S1 domain that mediates binding with 98 cellular receptors and a carboxy-terminal (CT) S2 domain that mediates subsequent virus-cell 99 membrane fusions. A wide-range of diverse cellular receptors specifically recognized by the 100 S1 domains has been identified for all the aforementioned hCoVs except hCoV-HKU1. 101
Human aminopeptidase N (CD13) is the cellular receptor for hCoV-229E (9). 9-O-acytylated 102 sialic acid (9-O-Ac-Sia) is the cellular receptor determinant for hCoV-OC43 (10). hCoV-NL63 103 and SARS-CoV both employ human angiotensin-converting enzyme 2 (ACE2) to mediate 104 cellular entry (11, 12) , while hCoV-NL63 utilizes heparan sulfate proteoglycans for attachment 105 to target cells (13). MERS-CoV utilizes dipeptidyl peptidase 4 (DPP4 or CD26) receptor to 106 enter host cells (14) . 107
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HCoV-HKU1 was initially identified in 2005 from a pneumonia patient in Hong Kong (15) . 108
It was subsequently found to be as common and widespread as previously known hCoVs, 109 hCoV-229E, hCoV-OC43 and hCoV-NL63 (16) (17) (18) (19) . Characterization of hCoV-HKU1 has been 110 challenging due to the lack of a convenient cell line-based culture system. It was recently 111 demonstrated that hCoV-HKU1 replicates to high titer in an in vitro culture system that uses To date the function and role of the hCoV-HKU1 HE protein remains undefined. 129 6 / 25 vitro replication model, we further demonstrated that the HE protein but not an enzymatically 137 inactive HE mutant acted as a RDE and completely blocked or greatly reduced infection 138 depending on the dose of inoculating hCoV-HKU1. These findings revealed that early viral 139 entry steps for hCoV-HKU1 are similar to but also distinct from other members of group 2a 140
CoVs. Like hCoV-OC43 and BCoV, hCoV-HKU1 employs O-acytylated sialic acids as a 141 primary receptor determinant or attachment factor and its HE protein as corresponding RDE; 142 however, hCoV-HKU1 also uniquely requires additional receptor determinants than 143 hCoV-OC43 and BCoV. 144 145
Materials and Methods 146 147
Construction of expression plasmids. A synthetic codon-optimized sequence for the 148 HKU1-S1 gene (Genebank accession number NC_006577.2) encoding aa15-600 was cloned 149 into a mammalian expression vector containing a CD5 signal peptide and a C-terminal Fc tag 150 from mouse IgG2a (mFc). The expression cassette was under a CAG (CMV early 151 enhancer/chicken β actin) promoter. The resulting construct, pCAGGS-HKU1-S1(600)-mFc, 152 encodes a chimeric S1 protein with an N-terminal CD5 signal peptide and mFc at its C 153 terminus. Similarly, plasmids encoding other proteins were constructed, including the NT 154 domain of HKU1-S1 (aa15-268), the NT domain of hCoV-OC43-S1 (aa15-268) (ATCC 155 VR-759 strain, AAT84354), NT domain of S1 of CoV-HKU3 (aa16-323) (DQ022305). The 156 extracellular domain of HE proteins from different CoVs were also similarly constructed, 157
including HKU1-HE (aa14-358, NC_006577.2), hCoV-OC43-HE protein (aa19-376, 158 AAX85668.1), BCoV-HE (aa19-377, AAA92991.1), and MHV-S-HE (aa 25-393, AAX08110.1). 159
Plasmids encoding mutants of HKU1-HE were generated by site-directed QuikChange 160 mutagenesis method (Stratagene). All mutations were confirmed by DNA sequencing, in 161 which the codon for the esterase catalytic residue Ser40 was substituted by Ala (S40A mutant) 162 or the catalytic triad S40, H329, and D326 were all substituted by Ala (S40A/H329A/D326A). Technology). Tissue culture supernatants were harvested 3 days after transfection, and the 168 recombinant proteins were purified by protein A-affinity chromatography. 169
170
Flow cytometry (FACS) analysis. HKU1-S1(600)-mFc or other proteins at different 171 concentrations were diluted in FACS buffer (PBS containing 0.5% BSA and 0.1% NaN 3 ) and 172 then incubated with 0.5-1x10 6 of RD cells or red blood cells (RBCs) from mouse or rat blood 173 samples at 4ºC for 0.5-1 hr. Cells were then washed three times with FACS buffer and 174 followed by incubation with FITC-labeled anti-mouse Fc antibody at a dilution following the 175 manufacturer's instruction (Sigma or Pierce) at 4 ºC for 30 mins. Cells were washed as above, 176 and the binding of proteins to cells was analyzed by a BD FACS LSRII (Beckon,Dickinson) 177 flow cytometer and FCS Express software (De NoVo Software). For FACS analysis to 178 examine the inhibition of HKU1-S1 binding to RD cells, the cells were pretreated with 179 indicated HE proteins or enzymes at different concentrations, then incubated with HKU1-S1 180 and analyzed binding as described above. The NA was from clostridium perfringens (Sigma), 181 trypsin was from bovine pancreas and TPCK-treated (Sigma). For both NA and trypsin, the 182 pretreatment was carried out at 37 ºC for 1 hr ; for HE proteins the pretreatment was carried 183 out at 4 ºC for 1 hr. 184 185 Indirect immunofluorescence. RD cells were seeded on glass cover slips one day before 186 staining. Cells were washed three times with PBS, blocked with 0.5%BSA/PBS at 37 ºC for 30 187 mins, incubated with HKU1-600-mFc or HKU3-323-mFc at 20 μg/mL in PBS at 4 ºC for 1 hr, 188 followed by washing three times with PBS, then incubated with FITC-Goat anti-Mouse Fc 189 antibody (Sigma) at 4 ºC for 1 hr. Cells were washed three times, then incubated with 5 μg/mL 190 Hoechst 33258 at 37 ºC for 10 mins, followed by three additional washes and finally incubated 191 shown. 194
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As CoV S1 domains generally mediate the interactions with cellular receptor(s) to trigger 253 subsequent viral-host cell membrane fusion to initiate viral entry, we first expressed codon 254 optimized soluble HKU1 S1 domain (amino acids (aa) 15 to 600) and fused it to the Fc domain 255 from murine IgG2a (HKU1-S1(600)-mFc) ( Fig. 1A ) to identify the cellular receptor/attachment 256 factor for hCoV-HKU1. As a control, we also expressed the NT of the bat coronavirus HKU3 257 (29) S1 domain (aa16-323) fused to mFc, HKU3-S1(323)-mFc. To determine, which if any, 258 immortalized cell lines expressed the cellular receptor for hCoV-HKU1, we probed cell lines 259 that were isolated from several different species and tissues with our HKU1-S1 protein using (African green monkey kidney cells). Interestingly, only RD cells showed specific strong 267 binding with 5 μg/mL of HKU1-S1(600)-mFc as compared with the control protein ( Fig. 1B -268 left), no specific binding was found for all other cell lines tested, a representative negative 269 staining result on HeLa cells was shown in Fig.1B -right. To independently confirm that 270 HKU1-S1 binds to the surface of RD cells, we incubated cells with either HKU1-S1(600) or 271 HKU3-S1(323) followed by fluorescent-labeled secondary antibody and then used FM-4-64, a 272 lipophilic probe that fluoresces intensely upon binding to the outer leaf of the plasma 273 membrane. As shown in Fig. 1C -left, HKU1-S1(600) and FM-4-64 had similar staining 274 patterns on the cell membrane of RD cells, suggesting that both were labeling the surface of 275 the cells. In contrast, no HKU3-S1(323) could be detected on the surface of the RD cells ( Fig.  276 1C -right). FACS analysis also showed that the binding of HKU1-S1 with RD cells was in a 277 dose-dependent manner (Fig. 1D) , the binding can be detected at a low concentration of 278 HKU1-S1(600)-mFc protein at 0.61 μg/mL. These results indicate that a cellular attachment 279 factor or receptor(s) for hCoV-HKU1 is present on the surface of the RD cells. We further 280 tested whether the HKU1-S1's NT can bind with RD cells. The NT aa15-268 of HKU1-S1 was 281 11 / 25 expressed as a mFc-fusion protein (HKU1-S1(268)-mFc) (Fig. 1A) , and analyzed for binding 282 with RD cells by FACS analysis. As shown in Fig. 1E -left, the NT domain did not bind to RD 283 cells even at a high concentration of 10 μg/mL, suggesting that the binding of HKU1-S1 to RD 284 cells requires regions beyond the NT of S1, the NT domain alone is not sufficient to support 285 the binding. In contrast, the NT of hCoV-OC43-S1(268) protein could bind to RD cells in a 286 dose dependent manner ( Fig. 1E -right) , but the binding activity was relatively weaker than 287 that of HKU1-S1(600) to RD cells. 288 289
Binding of HKU1-S1 to RD cells is sialic acid dependent. 290
Sialic acids serve as attachment factors or receptors for a number of viruses (28, 30, 31). 291 9-O-Ac-sia was found to be essential for viral entry of BCoV and hCoV-OC43 (10, 30). To 292 investigate whether sialic acids are also involved in the binding of HKU1-S1 to RD cells, we 293 first pretreated cells with neuraminidase (NA), a sialidase that removes terminal free or 294 modified sialic acids which are α2,3-, α2,6-or α2,8-linked to the subterminal residue of a 295 sugar chain. Treated cells were then incubated with 5 μg/mL of HKU1-S1(600)-mFc. As 296 shown in Fig. 2A -left, pretreatment with NA ranging from 20-500 mU/mL markedly reduced 297 the binding of HKU1-S1(600) to RD cells in a dose-dependent manner; 500 mU/mL of NA 298
reduced the binding to about 3-5% of the levels observed in the mock treated cells. Similarly, 299
NA treatment of RD cells resulted in the reduction of OC43-S1(268)-mFc binding ( Fig. 2A  300 -middle). Whereas a control protein SIRPα binding to RD cells via its protein receptor CD47 301 (32) expressed on RD cell surface was not affected by NA treatment ( Fig. 2A -right) . This 302 result indicated that cell surface sialic acids participated in the binding of HKU1-S1(600) 303 protein to RD cells. To further test whether sialic acids involved in the binding are attached to 304 glycoprotein(s), RD cells were pretreated with TPCK-trypsin protease and then inoculated 305 with 5 μg/mL of HKU1-S1(600)-mFc. As shown in Fig. 2B , pretreatment with trypsin 306 dose-dependently reduced the binding of HKU1-S1 to RD cells, the maximum dose tested at 307 20 μg/mL trypsin reduced the binding to about 20% of the levels in the mock treated cells. 308
Trypsin treatment also similarly reduced binding of OC43-S1 to RD cells. Taken together, 309 these findings suggest that HKU1-S1 protein, similar to OC43-S1, can bind to sialic acids that 12 / 25 are attached to glycoprotein(s). 311 312 Unlike S1 of hCoV-OC43, HKU1-S1 cannot bind to 9-O-acetylated sialic acid containing 313 glycoprotein or RBCs. 314
To understand the sialic acid specificity and preference of HKU1-S1, bovine submaxillary 315 mucin (BSM), which mainly contains 9-O-Ac-sia and 8,9-di-O-Ac-sia (33), was first tested for 316 binding with HKU-S1 by ELISA. As shown in Fig. 2C , no binding was observed for BSM 317 coated on ELISA plate, whereas the positive control OC43-S1(268)-mFc bound to BSM under 318 the same condition tested. 319 Engagement of sialic acid by viruses usually correlates with the capacity to agglutinate 320 red blood cells (RBCs) from different animal species. hCoV-OC43 and influenza C viruses use 321 9-O-Ac-sia for attachment, and consequently both viruses have hemagglutination (HA) 322 activity specific for rat and mouse RBCs, which have a high concentration of 9-O-Ac-sia on 323 their surface (33, 34), but not for human, sheep, or horse RBC as they have little to no 324 9-O-Ac-sia expressed (10, 35, 36). Using OC43-S1(268)-mFc protein as a positive control, 325 both rat and mouse RBCs could be agglutinated by the OC43-S1 protein dose-dependently 326 as expected, but HKU1-S1(600) protein showed no HA activity on RBCs from both species 327 ( Fig. 2D) . Consistently, HKU1-S1 showed no binding whereas OC43-S1 strongly bound to 328 both RBCs dose-dependently in a FACS analysis ( Fig. 2E) . These results suggest that 329 hCoV-HKU1 is different from influenza C, hCoV-OC43 and BCoV in using 9-O-Ac-sia as a 330 binding determinant, 9-O-Ac-sia alone at least is not sufficient to mediate entry for 331 hCoV-HKU1. 332
333

HKU1-HE is an O-acetylesterase and possesses RDE activity 334
By sequence similarity analysis, the HE protein of HKU1 was predicted to have a 335 hemagglutinin domain and a putative sia-O-acetyl-esterase active site (15). However there is 336 only 50-57% amino acid conservation between the HKU1-HE and those of other group 2a 337
CoVs. Currently no function for HKU1-HE during infection has been demonstrated. 338
Sia-O-acetylesterases and NAs are two types of viral RDEs identified so far.
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Sia-O-acetylesterases, e.g. 9-O-acetylesterase, which was originally found in influenza C 340 (HKU1-HE-mFc) (Fig. 3A) . When HKU1-HE-mFc protein was incubated with RD cells, no 347 direct binding was detected ( Fig. 3B) . This result suggests that HKU1-HE is unlikely to 348 mediate viral attachment. To determine if the HKU1-HE protein has RDE activity, RD cells 349
were pretreated with HKU1-HE-mFc protein, and then incubated with HKU1-S1(600)-mFc, 350
followed by FACS to determine how much HKU1-S1(600) could still bind to the RD cells. 351
Remarkably, pretreatment of RD cells with HKU1-HE dramatically reduced the binding of S1 352 to RD cells in a dose-dependent manner (Fig. 3C) , similar to the reduction seen followed NA 353 pretreatment. This indicates that the HKU1-HE serves as a RDE for hCoV-HKU1, possessing 354 enzymatic activities capable of cleaving off the binding determinants for the S protein of HKU1 355 from the surface of the host cell. We next expressed OC43-HE, BCoV-HE and MHV-S-HE 356 proteins ( Fig. 3A) and compared their RDE activities on RD cells to HKU1-HE's activity in 357 eliminating HKU1-S1 or OC43-S1 binding to the cells. Similar to HKU1-HE, these HE proteins 358 showed no direct binding to RD cells by FACS analysis (Data not shown). Interestingly, 359 HKU1-HE pretreatment also reduced OC43-S1 binding to RD cells; and vice versa 360 pretreatment of cells with OC43-HE not only blocked OC43-S1 binding but also the binding of 361 HKU1-S1 ( Fig. 3C) ; BCoV-HE had the same activities as OC43 in acting as a RDE for both 362 HKU1-S1 and OC43-S1 on RD cells; whereas pretreatment of RD cells with MHV-S-HE, 363
which is a 4-O-acetylesterase, had no effects on the binding of both HKU1-S1 and OC43-S1 364 ( Fig. 3C) . Furthermore the HA activity of OC43-S1 on rat and mouse RBCs were not only 365 inhibited by OC43-and BCoV-HE but also HKU1-HE, whereas MHV-S-HE had no effect ( Fig.  366   3D) . These results suggest that HKU1-HE has similar 9-O-acetylesterase activity as 367 OC43-HE and BCoV-HE, but different from MHV-S-HE. 368
To further confirm that HKU1-HE indeed acts as a RDE solely by its sia-O-acetylesterase 369 activity, we first determined if HKU1-HE had any neuraminidase activity using an Amplex red 370 neuraminidase assay kit. As expected HKU1-HE had no detectable NA activity (data not 371 shown). On the other hand, HKU1-HE protein showed strong acetylesterase activity as 372 measured by using chromogenic p-nitrophenyl acetate (pNPA) as substrate (Fig. 3E) . BCoV-HE and MHV-S-HE were measured for acetylesterase activity, they all showed stronger 376 acetylesterase activity than HKU1-HE ( Fig. 3E) with parameters Km=1.20 ± 0.06mM, 377
Vmax=3.32±0.00 for OC43-HE, Km=1.50±0.09mM, Vmax=3.42±0.04 for BCoV-HE and 378
Km=1.25 ± 0.01mM, Vmax=3.34 ± 0.04 for MHV-S-HE, respectively. Considering that 379 HKU1-HE treatment has the same effect as NA treatment of RD cells on the HKU1-S1 binding 380
and it has no NA activity, it is conceivable that the HKU1-HE mediates RDE through its 381 sialate-9-O-acetylesterase activity similar to BCoV-and OC43-HE. 382
Sequence alignment of HKU1-HE protein against HEF of influenza C, HEs of hCoV-OC43, 383
BCoV, MHV and Toroviruses revealed that the conserved sialate-O-acetylesterase catalytic 384 active sites (S40, H329 and D326 catalytic triad (24)) are also present in HE protein of HKU1 385 ( Fig. 4A) . BCoV-HE mutant protein containing S40A substitution has been demonstrated to 386 be enzymatically inactive (24). To determine if the three amino acids were critical for the 387 acetylesterase activity of HKU1-HE, HE mutants containing single S40A or triple 388 S40A/H329A/D326A mutations were expressed and tested for their capacity to hydrolyze 389 pNPA substrate. As shown in Fig. 4B , both HE mutants completely lost esterase activity. 390
Furthermore, unlike the wild type HE protein, pretreatment of RD cells with these 391 acetylesterase inactive mutant HEs had no effect on HKU1-S1 protein binding to RD cells (Fig.  392   4C) . This result suggests that HKU1-S1 binding required specific type(s) of O-acetylated sialic 393 acids to be present on the cell surface, which corresponds to the sialic acid acetylesterase 394 specificity of the HKU1-HE. Considering that HKU1-S1 did not bind to 9-O-Ac containing BSM 395
and RBCs, combined with the result that HKU1-HE and OC43-HE mutually served as RDE for 396 their S1 proteins binding to RD cells, it is very likely that the acetyl modification at 9-O position 397 15 / 25 of sialic acid is a necessary but not sufficient binding determinant for HKU1-S protein. Pre-incubation of HAE with HKU1-HE protein inhibited viral replication suggesting that 422 HKU1-HE can destroy sialic acid moieties required for hCoV-HKU1 entry. When a lower titer 423 of HKU1 virus inocula was used, HKU1-HE protein at 100 μg/mL completely blocked 424 hCoV-HKU1 replication in HAE, whereas an enzymatic inactive HE variant HKU1-HE-S40A 425 showed no inhibition activity (Fig. 4E) . These results demonstrate that hCoV-HKU1 uses binding with 9-O-Ac-Sia is essential for these viruses to initiate infection and their S protein is 441 the major viral protein responsible for the binding. In this study, we found that the S protein of 442 hCoV-HKU1 can also recognize O-Ac-Sia but only those presented on RD cells among the 443 many cell lines tested. Different from the aforementioned CoVs in the same group, no binding 444 of hCoV-HKU1 S1 with 9-O-Ac-Sia containing BSM as well as RBCs from mouse and rat 445 could be detected. In addition, a previous study (42) and our data ( Fig. 1E ) both demonstrated 446 that the NT of HKU1-S1 was unable to bind with carbohydrate moieties, in contrast the 447 carbohydrate receptor binding domains for hCoV-OC43 and BCoV were located in the NT of 448 S1 (Fig. 2) (42) . On the other hand, for both hCoV-HKU1 and other 9-O-Ac-Sia-recognition 449 dependent CoVs, the question remains as to whether in addition to O-Ac-Sia, they also 450 interact with a protein receptor during the entry process. O-Ac-Sia on RD cells can be 451 recognized by hCoV-HKU1 S1 protein, however the cells are not permissive for viral infection. 452
One explanation for this is the lack of a protein receptor for hCoV-HKU1 on RD cells. In line 453 with this, our attempts using HKU1-S1(600) as a viral ligand protein for immunoprecipitation 454 and combining with mass spectrometric identification did not find a protein(s) specific binding 455 to HKU1-S1 (data not shown). It is also possible that there are other molecule(s) present only 456 in HAE cultures but not on RD cells, which are important for viral infection at a later stage, e.g. 457 membrane fusion or viral replication; or a restriction factor(s) that may exist in RD cells to limit 458 viral infection. Sia substrate binding (23). In our study, HKU1-HE indeed showed strong O-AC-esterase 481 activity with pNPA substrate, and the Ser-His-Asp catalytic triad mutant HEs completely lost 482 this activity. We demonstrated that the sialic acids expressed by RD cells are not only 483 specifically recognized by the HKU1-S1 protein but also are substrates for HE protein. 484
Wild-type but not mutant HE treatment of RD cells showed similar effect as neuraminidase 485 and abolished the subsequent binding of S1 to RD cells. These results indicate that the S1 486 protein binds with O-Ac-Sia and the HE has the matching Sia-O-Ac or even broader esterase 487 activity. Consistently, we demonstrated that HKU1-HE had similar RDE activity as OC43-HE and 492
BCoV-HE to remove the binding moiety from RD cells for S1 proteins of both HKU1 and OC43. 493
These results strongly support that HKU1-HE has similar Sia-9-O-Ac-esterase activity as 494 OC43-HE and BCoV-HE. However, unlike the S1 of OC43, Sia-9-O-AC binding activity was 495 not detected for the S1 of hCoV-HKU1 by BSM binding and erythrocytes hemagglutination 496 assays which are standard methods for examining the usage of Sia-9-O-AC as a receptor by 497 other CoVs (Fig. 2C-E) . Thus it is likely that HKU1 is different than OC43 and BCoV in terms 498 of using Sia-9-O-AC as a receptor via its Spike. Sia-9-O-AC may be required but not sufficient 499 to support the HKU1-S1 binding. In addition of Sia-9-O-AC, RD cells may express other type 500 of O-Acetylated sialic acid that is lacking or at lower level in BSM and erythrocyte cell surface 501 but required for HKU1-S1 recognition. One may also speculate that certain di-O-Ac-Sia, 502 tri-O-Ac-Sia or oligo-O-acetylated Sia in which all have an acetyl group at C9 (9-O-AC) in 503 common; or certain particular sugar chain core structure(s) to which Sia-9-O-Ac attached or 504 the linkage of sialic acid to the penultimate residue of a sugar chain may also be required. 505
506
Finally, in HAE cultures, we demonstrated that NA and HKU1-HE but not enzymatic 507 inactive HE mutant dramatically reduced virus infection or completely blocked infection when 508 lower viral challenge dose was applied. Treatment of HAEs with NA and HKU1-HE prior to 509 infection strongly suggests that the sia-9-O-AC-esterase activity of HE acted as a RDE and 510 removed the critical receptor binding moieties so that the early viral entry was impaired. 511
Considering the HAE cells continuously secret large amount of mucus, the effect of inhibition 512 of viral infection by pretreatment of the cells with NA and HE is remarkable and suggests an 513 19 / 25 essential role for sialic acids to initiate infection. Our study also suggests that acetyl 514 modification at 9-O of sialic acid may be a necessary but not sufficient receptor or attachment 515 factor determinant, and warrants further investigation to determine the fine specificity and 516 preference of sialic acids recognized by HKU1-S protein. Nevertheless, for the first time this 517 study provided experimental evidence to support O-Ac-Sia, by interacting with S1 of 518 hCoV-HKU1, serves as an essential determinant for viral attachment during the early entry 519 step, and HE possesses 9-O-AC-esterase or even broader activity and primarily acts as a 520 recombinant S1 or control proteins. All proteins were expressed in 293T cells and purified by 530 protein A sepharose beads. Purified proteins were run on SDS-PAGE and stained by 531 coomassie blue. (B) FACS analysis of HKU1-S1(600)-mFc (5 μg/mL) binding to RD and Hela 532 cells. HKU3-323-mFc was used a negative control protein. (C) HKU1-S1(600)-mFc 533 binding to a molecule(s) located on RD cell surface. Immunofluorescence microscopy imaging 534 of RD cells stained by HKU1-S1(600)-mFc or control protein, HKU3-323-mFc. Cells 535 membrane was stained with FM-4-64 in red, Hoechst dye 33258 stained the nuclei (blue), and 536 the HKU1-S1 staining was detected by a FITC-labeled anti-mouse Fc antibody. (D) 537 HKU1-S1(600)-mFc binding to RD cells in a dose dependent manner in a FACS analysis. (E) 538 FACS analysis of the N-terminals of HKU1-S1 and OC43-S1 binding to RD cells. 539 HKU3-323-mFc at 10 μg/mL was used as a control (labeled as Ctrl.) in panels D and E. 540 binding in a dose-dependent manner. RD cells were pretreated with NA at different 546 concentrations as indicated and then stained with 5 μg/mL of HKU1-S1(600)-mFc, 547 OC43(268)-mFc or SIRPα-mFc control protein, respectively, then followed by detecting with a 548
FITC-labeled anti-mouse Fc antibody. (B) Pretreatment of RD cells with TPCK-treated Trypsin 549
reduced HKU1-S1(600) and OC43-S1(268) binding to RD cells. The FACS assay method was 550 similar as described in panel A. Ctrl. indicates RD cells were stained with HKU1-S1(268)-mFc 551 only in panel A and B. (C) HKU1-S1(600)-mFc did not bind to BSM (containing 9-O-Ac-sia) 552 directly coated on ELISA plate. OC43-S1 served as a positive control. (D) HKU-S1 did not 553 hemagglutinate mouse or rat RBCs. OC43-S1(268)-mFc served as a positive control and 554 showed HA activity dose-dependently. (E) Binding of HKU1-S1 and OC43-S1 to rat and 555 mouse RBCs by FACS analysis. Data shown are reprehensive of at least two independent 556 experiments for each panel. acted as a RDE on RD cells for HKU1-and OC43-S1 protein. Pretreatment of RD cells with 563 HKU1-HE as well as OC43-and BCoV-HE greatly reduced HKU1-S1 or OC43-S1 (at 5 μg/mL) 564 binding to RD cells in a dose-dependent manner. MHV-S-HE showed no effect. Graphs 565 shown in panel B-C are reprehensive of at least two independent experiments. (D) HKU1-HE 566 acted as a RDE on RBCs for OC43-S1 protein. Pretreatment of rat or mouse RBCs with 567 HKU1-, OC43-, BCoV-HE inhibited OC43-S1 mediated hemagglutination activity, whereas 568 MHV-S-HE had no effect. Representative data or images of at least two independent 569 experiments were shown for panels A-D. (E) HKU1-HE is an acetylesterase. HEs of HKU1, 570 OC43, BCoV and MHV-S at 2 μg/mL were used to hydrolyze pNPA (2-fold serially diluted) at 571 HKU1-S1(600)-mFc Ctrl.HKU3-S1-mFc 2.5 µg/mL 5 µg/mL 10 µg/mL 0.61 µg/mL HKU1-S1(268)-mFc HKU1-S1(600)-mFc
RD cell
HeLa cell
Ctrl. HKU3-S1(323)-mFc Cell only HKU1-S1(600)-mFc Counts FITC FITC FITC HKU1-S1(600)-mFc Ctrl. HKU3-S1(323)-mFc E OC43-S1(268)-mFc HKU1-S1(268)-mFc Ctrl. SIRPα α -mFc 26 17 FITC Fig. 1 . Specific binding of HKU1-S1 to RD cells. (A) SDS-PAGE of expressed recombinant S1 or control proteins. All proteins were expressed in 293T cells and purified by protein A sepharose beads. Purified proteins were run on SDS-PAGE and stained by coomassie blue. (B) FACS analysis of HKU1-S1(600)-mFc (5 µg/mL) binding to RD and Hela cells. HKU3-323-mFc was used a negative control protein. (C) HKU1-S1(600)-mFc binding to a molecule(s) located on RD cell surface. Immunofluorescence microscopy imaging of RD cells stained by HKU1-S1(600)-mFc or control protein, HKU3-323-mFc. Cells membrane was stained with FM-4-64 in red, Hoechst dye 33258 stained the nuclei (blue), and the HKU1-S1 staining was detected by a FITC-labeled anti-mouse Fc antibody. (D) HKU1-S1(600)-mFc binding to RD cells in a dose dependent manner in a FACS analysis. (E) FACS analysis of the N-terminals of HKU1-S1 and OC43-S1 binding to RD cells. HKU3-323-mFc at 10 µg/mL was used as a control (labeled as Ctrl.) in panels D and E. Graphs shown in panel B-E are reprehensive of at least two independent experiments for each panel.
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Fig. 2. Characterization of the binding receptor of HKU1-S1 protein on RD cells by FACS. (A) Pretreatment of RD cells with
Neuramidase (NA) greatly reduced HKU1-S1 binding in a dose-dependent manner. RD cells were pretreated with NA at different concentrations as indicated and then stained with 5 µg/mL of HKU1-S1(600)-mFc, OC43(268)-mFc or SIRPα-mFc control protein, respectively, then followed by detecting with a FITC-labeled anti-mouse Fc antibody. (B) Pretreatment of RD cells with TPCK-treated Trypsin reduced HKU1-S1(600) and OC43-S1(268) binding to RD cells. The FACS assay method was similar as described in panel A. Ctrl. indicates RD cells were stained with HKU1-S1(268)-mFc only in panel A and B. (C) HKU1-S1(600)-mFc did not bind to BSM (containing 9-O-Ac-sia) directly coated on ELISA plate. OC43-S1 served as a positive control. (D) HKU-S1 did not hemagglutinate mouse or rat RBCs. OC43-S1(268)-mFc served as a positive control and showed HA activity dose-dependently. (E) Binding of HKU1-S1 and OC43-S1 to rat and mouse RBCs by FACS analysis. Data shown are reprehensive of at least two independent experiments for each panel. 
[HE]
µ µg/mL HKU1-S1 only 0.61 10 Ctrl.
µ µg/mL OC43-S1 only HKU1-HE or the mutants at 1 µg/mL were incubated with 2-fold serially diluted pNPA at room temperature for 15 mins prior to measuring OD405. Each data points represent OD405 of HE or its mutants subtracted with that of a negative control. (C) Esterase inactive mutants of HE did not block HKU1-S1 protein binding to RD cells. RD cells were treated with 10 µg/mL of HE or HE mutant proteins prior to HKU1-S1 staining (5 µg/mL). (D) HE and NA pretreatment of HAE inhibited HKU1 infection. Prior to HKU1 virus inoculation, HAE cells were pretreated with HE proteins or NA at different concentrations as indicated for 1 hr, followed by HKU1 virus inoculation at high dose as indicated. Replication kinetics of HKU1 virus was assessed in apical washes from infected HAE cultures by real-time RT-PCR. Virus yield is presented as number of virus RNA copies/mL. (E) HE pretreatment blocked HKU1 infection of HAE cells. HAE were pretreated with HE protein or enzymatic inactive HE mutant (S40A) for 1 hour prior to viral challenge at lower dose than used panel D. Replication kinetics of HKU1 virus was assessed as in panel D. Dotted line indicates the detection limit of the assay for panel D-E.
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